lets not forget that these guys are the recipients of non dilutive cash advances also. A traditional cap raise is far from certain. The costs of running the trials are just what they are, expensive. Nothing can change that.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-4
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
65.0¢ |
Change
-0.005(0.76%) |
Mkt cap ! $800.2M | |||
| Open | High | Low | Value | Volume |
| 64.0¢ | 65.5¢ | 63.5¢ | $1.977M | 3.065M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13502 | 64.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 65.5¢ | 15085 | 1 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| OPT (ASX) Chart |